ADAPY
Adaptimmune Therapeutics plc
USUnited States
Market capitalizationUSD 7.42MAs of 8/28/2026, 11:59:59 PM
Adaptimmune Therapeutics plc (ADAPY) is a publicly traded company listed on USA Stocks and associated with United States. Its latest validated market capitalization is USD 7.42M. The latest available share price is $0.03. Institution currently ranks it #24,773 globally by market capitalization.
Global rank#24,773
Country rank#5,602United States
Share price$0.03end of day
Market capUSD 7.42M
Share price$0.03
1D change+22.81%
Price history
Adjusted historical share price · USDPrice history unavailableCurrent market data remains available while historical price coverage is prepared.
Company profile
TickerADAPY
Primary listingUSA Stocks
CountryUnited States
Institution
Starting or running a U.S. company?
Institution coordinates incorporation, bookkeeping and tax preparation for modern businesses.